ESC 365 - COMPASS Trial - Bleeding and cancer risk in patients with vascular disease treated with Rivaroxaban

Back

ESC Premium Access

COMPASS Trial - Bleeding and cancer risk in patients with vascular disease treated with Rivaroxaban

Session: Clinical Trial Updates

Topic: Secondary Prevention

Speaker: Doctor J. Eikelboom (Hamilton, CA)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor John William Eikelboom

McMaster University, Hamilton (Canada)

37 presentations

0 follower

11 more presentations in this session

Discussant review - COMPASS.

Speaker: Professor L. Wallentin (Uppsala, SE)

Access

Slides

Video

CANTOS - Modulation of the Interleukin-6 Signaling Pathway and Incidence Rates of Atherosclerotic Events and Mortality

Speaker: Doctor P. Ridker (Boston, US)

Access

Slides

Video

Discussant review - CANTOS.

Speaker: Professor M. Packer (Dallas, US)

Access

Slides

Video

CABANA Trial - Recurrence of Atrial Arrhythmias in the Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation

Speaker: Professor J. Poole (Seattle, US)

Access

Slides

Video

Discussant review - CABANA.

Speaker: Professor C. Leclercq (Rennes, FR)

Access

Slides

Video

Access the full session

Clinical Trial Updates

Speakers: Doctor J. Eikelboom, Professor L. Wallentin, Doctor P. Ridker, Professor M. Packer, Professor J. Poole...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources